ESTA
Establishment Labs Holdings Inc.
NASDAQ · CRHealthcareMedical - Devices
$93.42+0.91%
Price as of Jul 20, 2026
ESTA growth
Establishment Labs Holdings Inc. growth
Reported trailing growth, forward expectations and three-year compound growth rates.
Trailing growth
Year over year
- Revenue
- +34.9%
- EBITDA
- +75.0%
- EBIT
- +50.8%
- EPS
- +52.5%
- Free cash flow
- +44.9%
- Operating cash flow
- +48.9%
Forward estimates
- Revenue
- +28.4%
- EBITDA
- —
- EPS
- +54.7%
Three-year CAGR
- Revenue
- +9.3%
- EBITDA
- +60.4%
- EBIT
- +22.0%
- Net income
- +39.6%
- EPS
- +42.7%
- Free cash flow
- +22.2%
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.